Literature DB >> 3502688

Mapping of a gene for X-linked agammaglobulinemia and evidence for genetic heterogeneity.

E J Mensink, A Thompson, J D Schot, W M van de Greef, L A Sandkuyl, R K Schuurman.   

Abstract

X-linked agammaglobulinemia (XLA) is a severe humoral immunodeficiency disease of man. The inheritance of the disease is X-linked recessive. Female carriers can not be distinguished by immunologic assays. We investigated the localization of the disease gene on the X chromosome, utilizing nine polymorphic X chromosomal markers. In a single eight generation pedigree we found close linkage of the disease gene to the restriction fragment length polymorphism (RFLP) recognized by the DNA probe p19-2; the maximum lod score was 3.30 at a recombination fraction of 0.06. Addition of the lod scores for p19-2 obtained from seven other XLA pedigrees did not show the expected increase of the total score. This suggested genetic heterogeneity. We used the p19-2 marker as a reference point to search for pedigrees which had the disease gene at a different location. One pedigree provided a lod score of -3.14 at a recombination fraction of 0.06 with the p19-2 marker. We postulate that XLA is not a single genetic entity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3502688     DOI: 10.1007/BF00279095

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

3.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

4.  B cells in patients with X-linked agammaglobulinemia.

Authors:  M E Conley
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

5.  Single-copy sequence hybridizes to polymorphic and homologous loci on human X and Y chromosomes.

Authors:  D Page; B de Martinville; D Barker; A Wyman; R White; U Francke; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

6.  A strategy to reveal high-frequency RFLPs along the human X chromosome.

Authors:  J Aldridge; L Kunkel; G Bruns; U Tantravahi; M Lalande; T Brewster; E Moreau; M Wilson; W Bromley; T Roderick
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

7.  Immunoglobulin gene rearrangement in immature B cells.

Authors:  R Maki; J Kearney; C Paige; S Tonegawa
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

8.  The genetic linkage map of the human X chromosome.

Authors:  D Drayna; R White
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

9.  X-linked agammaglobulinemia and the red blood cell determinants Xg and 12E7 are not closely linked.

Authors:  E J Mensink; J D Schot; P Tippett; J Ott; R K Schuurman
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states.

Authors:  E R Pearl; L B Vogler; A J Okos; W M Crist; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

View more
  19 in total

Review 1.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome.

Authors:  B Arveiler; G de Saint-Basile; A Fischer; C Griscelli; J L Mandel
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

3.  Differential methylation at the 5' and the 3' CCGG sites flanking the X chromosomal hypervariable DXS255 locus.

Authors:  R W Hendriks; M E Kraakman; R G Mensink; R K Schuurman
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

4.  Close linkage of probe p212 (DXS178) to X-linked agammaglobulinemia.

Authors:  S Guioli; B Arveiler; B Bardoni; L D Notarangelo; P Panina; M Duse; A Ugazio; I Oberlé; G de Saint Basile; J L Mandel
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

Review 5.  Prenatal diagnosis and carrier detection in primary immunodeficiency disorders.

Authors:  Y L Lau; R J Levinsky
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

6.  Evidence for male X chromosomal mosaicism in X-linked agammaglobulinemia.

Authors:  R W Hendriks; E J Mensink; M E Kraakman; A Thompson; R K Schuurman
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

7.  Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13.

Authors:  G de Saint Basile; B Arveiler; I Oberlé; S Malcolm; R J Levinsky; Y L Lau; M Hofker; M Debre; A Fischer; C Griscelli
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 8.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

9.  Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.

Authors:  Y Ohta; R N Haire; R T Litman; S M Fu; R P Nelson; J Kratz; S J Kornfeld; M de la Morena; R A Good; G W Litman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region.

Authors:  F P Cremers; R A Pfeiffer; T J van de Pol; M H Hofker; T A Kruse; B Wieringa; H H Ropers
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.